欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/5669/002
药品名称Lisinopril/Hydrochloorthiazide Viatris 20/12,5 mg, tabletten
活性成分
    • Hydrochlorthiazide 12.5 mg
    • Lisinopril as lisinopril dihydrate 20.0 mg
剂型Tablet
上市许可持有人Viatris Ltd Damastown Industrial Park Mulhuddart Dublin 15 Dublin Ireland
参考成员国 - 产品名称Netherlands (NL)
Lisinopril/Hydrochloorthiazide Viatris 20/12,5 mg, tabletten
互认成员国 - 产品名称
    • Belgium (BE)
      Co-Lisinopril Viatris 20/12,5 mg tablet
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Portugal (PT)
    • Italy (IT)
许可日期2008/04/05
最近更新日期2024/03/28
药物ATC编码
    • C09BA03 lisinopril and diuretics
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase